MedTech Acquisition Corp (MTAC) Key Ratios
$11.34
As on 10-Aug-2023 16:00EDT
Market cap
$84 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
226.8
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -69.56 | -396.05 | 63.02 | -- | -- |
| Net Profit | -122.06 | -141.70 | -2,161.78 | -- | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -31.78 | 62.55 | 61.06 |
| Return on equity
| -- | -- | -- | 4.62 | 2.00 |
| Return on Capital
| -- | -- | -- | 4.56 | 2.00 |
| Return on Assets
| -- | -- | -0.83 | 4.09 | 1.90 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.36 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
--
|
4.56
|
2.00
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
--
|
4.62
|
2.00
|
--
|
--
|
|
Peer Median
|
24.06
|
--
|
--
|
--
|
--
|
ROA
-0.83
Higher than Peers by 1.74
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
-0.83
|
4.09
|
1.90
|
--
|
--
|
|
Peer Median
|
-2.58
|
--
|
--
|
--
|
--
|
Net Margin
-31.78
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
-31.78
|
62.55
|
61.06
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
63.02
Higher than Peers by 5.23
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
63.02
|
9.69
|
-834.23
|
--
|
--
|
|
Peer Median
|
57.78
|
--
|
--
|
--
|
--
|
Net Profit Growth
-2,161.78
Lower than Peers by 2,133.10
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
-2,161.78
|
16.19
|
4,631.85
|
--
|
--
|
|
Peer Median
|
-28.68
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
--
|
0.36
|
0.00
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.08
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
-1.08
|
0.16
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.03
Lower than Peers by 0.12
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
0.03
|
0.14
|
0.50
|
19.46
|
--
|
|
Peer Median
|
0.15
|
--
|
--
|
--
|
--
|
Quick Ratio
0.03
Lower than Peers by 0.11
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
0.03
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.13
|
--
|
--
|
--
|
--
|
Interest Coverage
0.94
Lower than Peers by 0.72
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
0.94
|
-0.31
|
-47.51
|
--
|
--
|
|
Peer Median
|
1.66
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
226.80
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
226.80
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
1.31
Lower than Peers by 2.08
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
1.31
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.39
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-124.12
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
-124.12
|
2.05
|
23.15
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
84
Higher than Peers by 75
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
MedTech Acquisition Corp (MTAC)
|
84
|
--
|
--
|
--
|
--
|
|
Peer Median
|
9
|
--
|
--
|
--
|
--
|